Eyestem Research Overview
- Headquarters
- In
- Industry
- Biotechnology
- Employees
- 19
- Funding
- 6.4M
About Eyestem Research
Current cell and gene therapy products are estimated to cost >$250k per injection. This is unsustainable. Our vision is to democratize access to cell therapy and provide benefits to a larger section of humanity We intend to disrupt the global cell therapy ecosystem and set a new benchmark for quality and affordability in this sector. Eyecyte-RPE-our flagship project to treat incurable macular degeneration has excellent efficacy results and will be in FIM trials in 2021.
Eyestem Research Contact Details
- People in AeroLeads
- 4
- With contact data
- 2
- Email contacts
- 2
- 50.0% coverage
Eyestem Research Org Chart
Sample employees and titles| Name | Title | Location | Contact |
|---|---|---|---|
| Rajarshi Pal, Ph.d. | Co-founder & Chief Scientist, Eyestem |
View
|
|
| Vijay Konala, Ph.d. | Head: Product Development & Compliance | Navi Mumbai, Maharashtra, India |
Email
|
| Dr. Ramesh Byrapaneni | Managing Director, Endiya Partners | Greater Hyderabad Area, India |
Email
|
| Ramaswamy Subramanian | Professor/ Gerald and Edna Mann | West Lafayette, Indiana, United States |
View
|
Employees by Management Level
Individual contributor
2 profiles
Executive
1 profile
Director
1 profile
Compare Similar Companies to Eyestem Research
Sea6 Energy Pvt Ltd.
Biotechnology Research
String Bio Private Limited
Biotechnology Research
Immuneel Therapeutics Pvt. Ltd.
Biotechnology Research
GangaGen Biotechnologies
Biotechnology Research
Stempeutics Research Private Limited
Biotechnology Research
Bugworks Research Inc.
Biotechnology Research
Pandorum Technologies
Biotechnology
Zumutor Biologics
Biotechnology Research
NKure Therapeutics
Biotechnology Research
CyGenica Ltd.
Research